The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth.Published in:BioMed Research International, 2022, v. 2022, p. 1, doi. 10.1155/2022/9426623By:Begimbetova, Dinara;Kukanova, Assiya;Fazyl, Fatima;Manekenova, Kenzhekyz;Omarov, Talgat;Burska, Agata N.;Khamijan, Medina;Gulyayev, Alexandr;Yermekbayeva, Bakytgul;Makishev, Abay;Saliev, Timur;Batyrbekov, Kanat;Aitbayev, Chokan;Spatayev, Zhanat;Sarbassov, DosPublication type:Article